The long-term goal of the proposed work is to determine the role of sequence-specific DNA methylation in the regulation of photoreceptor gene expression. The work is designed to whether DNA regions that regulate gene expression are methylated at specific nucleotide bases in non- photoreceptor cells but unmethylated in photoreceptors. Experiments will be done to determine whether lack of methylation at specific DNA residues permits expression in photoreceptors but methylation prevents expression in other tissues. These questions are consequential because improper gene regulation of photoreceptor- specific proteins can cause retinal degenerations, color vision deficiencies, and quite likely an abundance of other pathologies. This research also is important in that it explores the previously unstudied regulatory role of low-density methylation in photoreceptors, as opposed to high-density methylation, which is relatively well-characterized in non-photoreceptor systems. DNA methylation will be mapped by conversion sequencing, a new technique in which DNA is chemically treated to discriminate methylated from unmethylated nucleotide bases in subsequent sequencing reactions. It is predicted that genes that are selectively expressed in photoreceptors will contain residues that are unmethylated in DNA isolated from photoreceptors but methylated in DNA from other cell types. It is further predicted that if hypomethylation permits gene expression in vivo, then hypomethylation patterns will appear prior to gene transcription initiation. To determine whether these methylation patters regulate gene expression, the effects of exogenous DNA methylation on gene promoter activity will be assessed with transient transfections of cultured retina, retinoblastoma, and non-retina cells. It is predicted that methylation at specific bases identified in mapping experiments will suppress gene promoter activity, thus establishing a causative role for site-specific hypomethylation in photoreceptor gene regulation.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY012514-02
Application #
6179072
Study Section
Visual Sciences C Study Section (VISC)
Program Officer
Mariani, Andrew P
Project Start
1999-05-03
Project End
2002-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
2
Fiscal Year
2000
Total Cost
$137,748
Indirect Cost
Name
Emory University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Phillips, M Joe; Walker, Tiffany A; Choi, Hee-Young et al. (2008) Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30. Invest Ophthalmol Vis Sci 49:2148-55
Chang, B; Hawes, N L; Pardue, M T et al. (2007) Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene. Vision Res 47:624-33
Boatright, Jeffrey H; Moring, Anisha G; McElroy, Clinton et al. (2006) Tool from ancient pharmacopoeia prevents vision loss. Mol Vis 12:1706-14
Andrieu-Soler, Charlotte; Casas, Mariana; Faussat, Anne-Marie et al. (2005) Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs. Nucleic Acids Res 33:3733-42
Boatright, J H; Stodulkova, E; Do, V T et al. (2002) The effect of retinoids and butyrate on the expression of CRX and IRBP in retinoblastoma cells. Vision Res 42:933-8
Boatright, J H; Borst, D E; Stodulkova, E et al. (2001) Endogenous CRX expression and IRBP promoter activity in retinoblastoma cells. Brain Res 916:136-42
Boatright, J H; Knox, B E; Jones, K M et al. (2001) Evidence of a tissue-restricting DNA regulatory element in the mouse IRBP promoter. FEBS Lett 504:27-30